L
Lorenz Trümper
Researcher at University of Göttingen
Publications - 276
Citations - 22696
Lorenz Trümper is an academic researcher from University of Göttingen. The author has contributed to research in topics: Lymphoma & Diffuse large B-cell lymphoma. The author has an hindex of 53, co-authored 260 publications receiving 19534 citations. Previous affiliations of Lorenz Trümper include Deutsche Forschungsgemeinschaft & University of Cologne.
Papers
More filters
Journal ArticleDOI
Significant dose Escalation of Idarubicin in the treatment of aggressive Non- Hodgkin Lymphoma leads to increased hematotoxicity without improvement in efficacy in comparison to standard CHOEP-14: 9-year follow up results of the CIVEP trial of the DSHNHL
Karin Hohloch,Carsten Zwick,Marita Ziepert,Dirk Hasenclever,Ulrich Kaiser,Andreas Engert,Heinz-Gert Höffkes,Frank Kroschinsky,Rolf M. Mesters,Andreas C Feller,Markus Löffler,Lorenz Trümper,Michael Pfreundschuh +12 more
TL;DR: Thus, idarubicin cannot be used instead doxorubicine even if its dose is escalated to achieve similar hematotoxicity, and DoxorUBicin remains the standard anthracycline for the treatment of aggressive NHL.
Journal Article
High dose mitoxantrone with thiotepa, cyclophosphamide and autologous stem cell rescue for high risk stage II and stage III breast cancer. German GABG-4/EH-93-Study.
Axel R. Zander,W Krüger,N Kröger,Lloyd E. Damon,M Königmann,We Berdel,F. Gieseking,K. Scháfer-Eckart,V Möbus,Norbert Frickhofen,Hannes Wandt,H J Illiger,B Metzner,Karin Kolbe,B Wörmann,Lorenz Trümper,C Huber,D. K. Hossfeld,H Maass,Jonat W +19 more
Journal ArticleDOI
The "Burkitt-like" immunophenotype and genotype is rarely encountered in diffuse large B cell lymphoma and high-grade B cell lymphoma, NOS.
Katrin Hüttl,Annette M. Staiger,Annette M. Staiger,Julia Richter,M. Michaela Ott,Sabrina Kalmbach,Wolfram Klapper,Anne-Sophie Biesdorf,Lorenz Trümper,Andreas Rosenwald,Marita Ziepert,Heike Horn,Heike Horn,German Ott +13 more
TL;DR: In this paper, a large-scale cohort of diffuse large B cell lymphoma (DLBCL) and HGBL cases was used to test the distinctiveness of the CD10+, BCL6+ BCL2-and MYCR positive immunopheno-genotype in a large cohort of >1000 DLBCL.
Journal ArticleDOI
Single cell PCR for the analysis of Hodgkin's disease: Four years later
TL;DR: Global cDNA amplification was successfully performed from single H & RS cells, and specific gene transcripts were detected with a novel PCR method, which will help to elucidate many of the open questions in the biology of Hodgkin's disease.
Journal ArticleDOI
Phase III trial of brentuximab vedotin and CHP versus CHOP in the frontline treatment of patients (pts) with CD30+ mature T-cell lymphomas (MTCL).
Owen A. O'Connor,Barbara Pro,Timothy M Illidge,Lorenz Trümper,Emily K. Larsen,Dana A. Kennedy +5 more
TL;DR: This data indicates that once-weekly dosing with anthracycline-based multiagent chemotherapy regimens for MTCL or systemic anaplastic large cell lymphoma is a viable treatment option for these patients with high response rates.